@FierceBiotech: Popular this weekend: Merck R&D calls for a time-out on osteo blockbuster hopeful. Story | Follow @FierceBiotech
@JohnCFierce: Interesting to see Medicines Co. pay Alnylam $25M upfront for early-stage PCSK9 program. More | Follow @JohnCFierce
@RyanMFierce: Gilead says SVR 67% in oral combo is same as SVR on interferon group in Ph3 FISSION study in hep C types 2&3, meets primary endpoint. Release | Follow @RyanMFierce
> Sanofi ($SNY) says that the EU has approved its diabetes drug Lyxumia. Report
> Chicago-based Novian Health has raised $11 million in a Series A designed to advance its work on a laser treatment for breast cancer. Release
> NanoViricides says it has raised $6 million from unnamed investors backing their first clinical study of their experimental flu drug. Release
Pharma News
@FiercePharma: U.S. government finally gets payment rule published. News | Follow @FiercePharma
@EricPFierce: AstraZeneca, Bristol-Myers Squibb create 'Diabetes Inc.,' to give complete attention to diabetes treatment sales. More | Follow @EricPFierce
@AlisonBFierce: A study of the first new TB vaccine in 90 years showed it offered no added benefit to the current vaccine. News | Follow @AlisonBFierce
> Exports to U.S. to power Indian drugmaker growth. Item
> Feds grab Shire's attention on Adderall marketing. Report
> Loss of Actos weighs heavily on Takeda. News
@FierceMedDev: Swiss team: Nanoscale tissue check boosts breast cancer Dx. More | Follow @FierceMedDev
@MarkHFierce: GE and the N.F.L. will jointly develop new imaging tech to spot concussions. News| Follow @MarkHFierce
@DamianFierce: Icon is spending $52M on Cross Country Healthcare's clinical trials business. Report | Follow @DamianFierce
> AdvaMed targets Puerto Rico device tax hike as unfair burden. News
> Covidien ticks toward pharma spinoff. Article
> Yogurt, pacemakers compel conflict-of-interest issues in Florida. Item
CRO News
> Parexel brightens 2013 outlook after strong quarter. Story
> BioClinica eyed for $123M buyout, eventual merger. News
> Indian clinical trials: Private group steps in to increase transparency. More
> Patheon brings bioavailability service to EU with plant expansion. Report
Biotech IT News
> Cypher Genomics chief speaks out from DNA data-crunching crowd. Story
> Clinical trials software player agrees to $123M buyout. News
> Boehringer unleashes iPhone app amid COPD blitz. Report
> Biopharma targets bioinformatics aces in R&D overhaul. Article
And Finally… Academic investigators in the U.K. say that an experimental therapy erased a third of the toxic plaque often associated with Alzheimer's disease in an animal study. Story